ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 2.845
-0.045 (-1.56%)
Nov 3, 2026, 4:08 PM HKT
HKG:1541 Market Cap
HKG:1541 has a market cap or net worth of 1.22 billion as of November 2, 2026. It is the 22,077th most valuable company in the world and the 1,033rd biggest in Hong Kong. Its market cap has decreased by 69.12% in one year.
Market Cap
1.22B
Enterprise Value
533.89M
Revenue
170.32M
Global Rank
Country Rank
#1,033 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since September 5, 2023, HKG:1541's market cap has decreased from 7.29B to 1.22B, a decrease of -83.23%. That is a compound annual growth rate of -43.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 1.22B | -51.42% |
| Dec 31, 2025 | 2.52B | 19.70% |
| Dec 31, 2024 | 2.10B | -81.21% |
| Dec 29, 2023 | 11.19B | 53.55% |
| Sep 5, 2023 | 7.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clover Biopharmaceuticals | 1.62B |
| PegBio | 1.60B |
| Guangzhou Innogen Pharmaceutical Group | 1.55B |
| SinoMab BioScience | 1.48B |
| Beijing Biostar Pharmaceuticals | 1.32B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.20B |
| TYK Medicines | 1.19B |
| Zhaoke Ophthalmology | 1.10B |